Background Both prophylactic and early surfactant replacement therapy reduce mortality
and pulmonary complications in ventilated infants with respiratory distress syndrome (RDS) …

OBJECTIVE: Early surfactant followed by extubation to nasal continuous positive airway
pressure (nCPAP) compared with later surfactant and mechanical ventilation (MV) reduce …

Current practice guidelines recommend administration of surfactant at or soon after birth in
preterm infants with respiratory distress syndrome. However, recent multicenter randomized …

Despite recent advances in the perinatal management of neonatal respiratory distress
syndrome (RDS), controversies still exist. We report the recommendations of a European …

Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and
mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory …

Non-invasive techniques of respiratory support were developed in order to reduce the
adverse effects associated with ventilation via an endotracheal tube. Short bi-nasal prongs …

Importance Surfactant administration by minimally invasive methods that allow for
spontaneous breathing might be safer and more effective than administration with …

Featuring the work of recognized worldwide experts, this user-friendly text presents the most
current scientific information, diagnostic approaches, and management strategies for the …

Background Cohort studies have suggested that nasal continuous positive airway pressure
(CPAP) starting in the immediate postnatal period before the onset of respiratory disease …

OBJECTIVE: To determine whether very low birth weight infants (VLBWIs), initially supported
with continuous positive airway pressure (CPAP) and then selectively treated with the …